10-Q: Syra Health Corp. Reports Q1 2025 Results: Revenue Up Slightly, Losses Narrow

Syra Health Corp.'s Q1 2025 results show a slight revenue increase and a significant reduction in net loss compared to the same period last year.

Summary

• Syra Health Corp. reported net revenues of $1.858 million for the three months ended March 31, 2025, compared to $1.752 million for the same period in 2024.
• The company's net loss decreased from $1.447 million in Q1 2024 to $472,265 in Q1 2025.
• Healthcare workforce revenue decreased to $655,217, while population health revenue increased to $1.203 million.
• The cost of services decreased by 13% to $1.269 million.
• Operating expenses decreased significantly from $1.744 million to $1.062 million.
• The company voluntarily delisted its Class A common stock from the Nasdaq Capital Market on April 11, 2025.
• The company acknowledges substantial doubt about its ability to continue as a going concern and may need to raise additional capital.
• The company is dependent on state, local and county government budgets for its revenue and has begun to see delays in new contract awards, or cancellations of previous requests for proposals.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While the company has shown improvement in reducing losses and managing expenses, concerns about its ability to continue as a going concern and the delisting from Nasdaq temper the positive aspects.

Positives

• The company experienced a significant decrease in net loss, indicating improved financial performance.
• Population health revenue increased, demonstrating growth in that segment.
• Operating expenses were significantly reduced, contributing to the reduced net loss.
• Gross profit margin improved, reflecting better efficiency and profitability.
• The company's cost of services decreased primarily due to a decrease in labor costs, and decreased consulting costs associated with a slight change in service mix from healthcare workforce services to project-based population health and digital health services that carry better margins.

Negatives

• Healthcare workforce revenue decreased, indicating challenges in that segment.
• The company acknowledges substantial doubt about its ability to continue as a going concern.
• The company voluntarily delisted its Class A common stock from the Nasdaq Capital Market on April 11, 2025.
• The company is dependent on state, local and county government budgets for its revenue and has begun to see delays in new contract awards, or cancellations of previous requests for proposals.

Risks

• The company's dependence on government funding makes it vulnerable to budget cuts and changes in priorities.
• The company's ability to continue as a going concern is uncertain, requiring potential additional financing.
• The delisting from Nasdaq could negatively impact investor confidence and stock liquidity.
• Delays in new contract awards and cancellations of previous requests for proposals are expected to negatively affect the quantity and time of our revenue, results of operations and cash flows in the near term.

Future Outlook

The company anticipates potential negative effects on revenue, results of operations, and cash flows due to delays in new contract awards and cancellations of previous requests for proposals, stemming from government spending reviews and potential changes in budgetary priorities.

Industry Context

The healthcare services industry is facing increasing pressure to improve efficiency and reduce costs, which is reflected in the company's efforts to streamline operations and reduce expenses. The company's focus on population health aligns with the broader industry trend towards preventative care and holistic wellness.

Comparison to Industry Standards

• It is difficult to compare Syra Health directly to industry standards without knowing specific competitors and their financial results.
• However, the company's gross profit margin of 32% in Q1 2025 can be compared to other healthcare service providers to assess its relative profitability.
• Companies like Teladoc Health and Amwell, which operate in the telehealth space, may serve as benchmarks for growth and market penetration in the digital health segment.
• Staffing agencies such as AMN Healthcare and Cross Country Healthcare could be used as benchmarks for the Healthcare Workforce segment.

Legal Proceedings

• In January 2025, the Company entered into a settlement agreement with a former employee for an immaterial amount and the case is dismissed.

Related Party Transactions

• The Company leases its current corporate headquarters under a lease from STVentures, LLC, an entity beneficially owned by the principal owners and the management team of Syra and their affiliates.
• The Company incurred costs for services from RAD CUBE LLC, which is an entity beneficially owned by the principal owners and the management team of Syra and their affiliates, for outsourced IT services.
• The Company paid for services from NLogix IT Services Private Limited and SKL Demand Private Limited, which are entities beneficially owned by the principal owners and the management team of Syra and their affiliates, for recruitment and human resource services.

Stakeholder Impact

• Shareholders may be concerned about the company's ability to continue as a going concern and the delisting from Nasdaq.
• Employees may face uncertainty due to potential cost-cutting measures and the need for additional financing.
• Customers may be affected by potential delays in contract awards and cancellations of projects.
• Suppliers and creditors may face increased risk due to the company's financial challenges.

Next Steps

• The company will continue to monitor its expenditures and cash flow position.
• The company will continue to pursue sources of additional capital through debt and financing transactions or arrangements, including equity financing or other means.
• The company will evaluate additional segment disclosure requirements as it expands its operations.

Key Dates

Keywords

healthcare services, population health, behavioral health, workforce staffing, financial results, Q1 2025, Syra Health, revenue, net loss, operating expenses